05:05 PM EST, 11/10/2025 (MT Newswires) -- Theravance Biopharma ( TBPH ) reported Q3 adjusted earnings late Monday of $0.04 per diluted share, swinging from a loss of $0.06 a year earlier.

Three analysts surveyed by FactSet expected a loss of $0.05.

Revenue for the three months ended Sept. 30 was $20 million, up from $16.9 million a year earlier.

Analysts polled by FactSet expected $20 million.